Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sildenafil (Viagra®) is effective in
improving cerebral blood flow and cerebrovascular reactivity inpatients who have persistent
symptoms at least 6 months after a traumatic brain injury (TBI).
Phase:
Phase 2
Details
Lead Sponsor:
Uniformed Services University of the Health Sciences
Collaborators:
Center for Neuroscience and Regenerative Medicine (CNRM) National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH)